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Diabetes is a metabolic disease caused by abnormal insulin secretion or action. In the present study, 
the effects of betulinic acid (BA, a triterpene) are evaluated on glucose, α-amylase and plasma insulin 
levels, insulin resistance and the histopathology of pancreatic islets in streptozotocin-nicotinamide (STZ-
NA) diabetic mice. Seventy adult male NMRI mice were randomly divided into seven groups: control, 
sham, diabetic, diabetic treated with BA (10, 20 and 40 mg/kg) and diabetic treated with metformin 
(200 mg/kg). Diabetes was induced in mice by intraperitoneal injection of streptozotocin 50 mg/kg after 
a dose of nicotinamide 120 mg/kg. Two weeks after treatment with BA, blood samples were collected 
for measuring glucose, α-amylase and insulin levels, and the pancreas was isolated for histopathology 
evaluation. Diabetes reduced the number and diameter of pancreatic islets, and increased α-amylase and 
insulin resistance. BA treatment reduced blood glucose, α-amylase and improved insulin sensitivity as 
well as pancreas histopathology. In addition, BA showed stronger effects on the pancreatic histology 
and insulin resistance compared to the metformin group.
Keywords: Betulinic acid. Diabetes. Mouse. Streptozotocin-nicotinamide.
INTRODUCTION 
Diabetes mellitus is a global health problem. Insulin 
deficiency leads to failure of glucose consumption in 
diabetes mellitus (DM) and breakdown of lipids and 
proteins (Mousavi et al., 2011). This disease causes 
cardiovascular disease, retinopathy, neuropathy and 
other long-term complications in uncontrolled conditions 
(Ahangarpour et al., 2016a).
In experimental studies, streptozotocin (STZ) - 
nicotinamide (NA) diabetic mice are one of the models 
that can induce mild diabetes (Tahara, Matsuyama-
Yokono, Shibasaki, 2011). STZ causes pancreatic β-cell 
damage with transport into β-cells via the glucose 
transporter (Glut2) and causes DNA damage; in contrast, 
NA partially protects against the harmful effects of 
STZ (Szkudelski, 2012). Nicotinamide prevents the 
diabetogenic effect of STZ via the NO product and 
prevents apoptosis, as well as having a protective effect 
in the first phase of insulin release (Alenzi, 2009). 
Rats treated with STZ and NA manifest symptoms of 
type 2 diabetes, while animals with STZ-induced type 
1 diabetes. β-cells in these rats were partly damaged, 
therefore insulin secretion was preserved in response 
to glucose and some other stimulants (Szkudelski, 
2012). Although several therapeutic agents have been 
used for diabetes mellitus treatment in recent decades, 
most therapeutic goals have remained unmet. So, a new 
approach is required for treatment of type 2 diabetes. 
Studies have shown that to treat and manage type 2 
diabetes and its complications, several long-used herbal 
medicines appear to be effective (Jeong et al., 2012); 
for example, triterpenoids, which are a large group 
of compounds present in many plants (Silva et al., 
2016). These compounds divide into lupane, oleonane 
and ursane groups (Jager et al., 2009). 3β-Hydroxy-
lup-20(29)-en-28-oic acid, betulinic acid (BA) is a 
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plant-derived pentacyclic triterpenoid of the lupane-type 
triterpenes. Betulinic acid can inhibit different enzymes 
related to carbohydrate/lipid absorption and metabolism, 
such as α-amylase (Yoshizumi et al., 2006), protein 
tyrosine phosphatase1B (Zhang et al., 2008), glycogen 
phosphorylase, and diacylglycerol acetyltransferase 
α-glucosidase (Zareen et al., 2008). Also, BA can 
increase insulin and leptin secretion (Melo et al., 2009). 
An in vitro incubation of BA in human aortic smooth 
muscle cell (HASMC) showed that BA can decrease the 
intracellular reactive oxygen species (ROS), and suppress 
the nuclear translocation and phosphorylation of IRB- α 
under high glucose conditions; therefore, BA can inhibit 
diabetic vascular disease (Yoon et al., 2010). BA has a 
preventive effect on diabetic nephropathy during diabetic 
situations (Ahangarpour et al., 2016b). In contrast, 
administration of BA in STZ-NA diabetic treated mice 
can induce a worse outcome in the male reproductive 
system (Ahangarpour et al., 2016c). BA can be useful 
for treatment and prevention of early atherosclerosis 
(Yoon et al., 2017). In obese rats with a high fat diet, BA 
inhibited TGR5 (a G protein-coupled receptor expressed 
in brown adipose tissues and muscles), and furthermore 
reduced body weight, abdominal fat accumulation, blood 
glucose, plasma triglyceride (TG) and total cholesterol 
(Melo et al., 2009). Hence, there is not enough evidence 
about the efficiency of the antidiabetic property of BA. 
This study was conducted to determine the effect of 
BA on α-amylase, and insulin levels, hyperglycemia 
and histological abnormalities of the pancreas in 
streptozotocin-nicotinamide induced diabetic mice, 
due to the lack of evidence on the efficiency of the anti-
diabetic properties of BA.
MATERIAL AND METHODS
Materials
Streptozotocin, nicotinamide, betulinic acid and 
metformin were purchased from Sigma- Aldrich CO (St. 
Louis, MO, USA). 
Animals
Adult male Naval Medical Research Institute 
(NMRI) mice (n=70, 5 weeks old, 25-35gr) were obtained 
from the Ahvaz Jundishapur University of Medical 
Sciences Animal Care Center (IRAN).
Animals were housed under a controlled temperature 
of 25 ºC and 12 h light–12 h dark cycle. All mice were 
allowed ad libitum access to food and water.
Experimental design
The mice were randomly divided into seven groups 
of ten animals: Controls were administered with a normal 
diet, Sham (received 0.1 mL normal saline i.p. daily for 2 
weeks), Type 2 diabetic as negative control (received STZ 
50 mg/kg in 0.1 mL citrate buffer pH 4.5, 15 min after a 
single dose of NA 120 mg/kg in 0.1 mL normal saline, 
i.p.), Type 2 diabetic + BA, received 10, 20 and 40 mg/
kg, in 0.3 mL normal saline (Xie et al., 2017) daily gavage 
for 2 weeks after induction of type 2 diabetes, and Type 2 
diabetic + metformin as positive control, received 200 mg/
kg in 0.3 mL normal saline, daily gavage for 2 weeks after 
induction of type 2 diabetes(Ahangarpour et al., 2016b).
Induction of animal model of type 2 diabetes
Diabetes was induced in overnight fasted mice, 
according to the method of Lee et al. (2010). Diabetes 
was induced in mice by intraperitoneal injection of 
streptozotocin 50 mg/kg after a dose of nicotinamide 120 
mg/kg. After 72 hours of the STZ-NA injection, blood 
glucose levels were determined and mice with blood 
glucose levels higher than 200 mg/dl were used in the 
following experiments.
Biochemical assessment
Blood glucose levels were determined by a 
glucometer (Elegance CT-X10, convergent technologies, 
Germany) and biochemical assay kits (Pars Azmoon, 
Iran), with a sensitivity of 0.1 mg/dl. Plasma α-amylase 
concentration was measured by a commercially available 
kit (Pars-Azmoon Co., Iran) using an Autoanalyzer device 
(BT3000, Italy), with a sensitivity of 1 IU/L. The plasma 
insulin level was evaluated by using ELISA assay kits 
(Monobind Inc, USA). The assay sensitivity was found 
to be 0.182 µIU/ml, while the inter-assay coefficient 
of variation (CV) was 7.2%, and the intra-assay CV 
was 4.3%. A homeostatic model assessment of insulin 
resistance (HOMA-IR), homeostatic model assessment 
of pancreatic β-cell function (HOMA-β), quantitative 
insulin sensitivity check index (QUICKI) and insulin 
disposition index (DI) were calculated by using the 
following formulae: 
HOMA-IR: fasting blood glucose (FBS) (mg/dL) × insulin 
(µIU/mL)/405
HOMA-β: 20 × insulin (µIU/mL)/ (FBS (mMol/L) - 3.5) 
QUICKI: 1/ (log FBS (mg/dL) + log insulin (µIU/mL)) 
(Ma et al., 2014)
DI: HOMA-β/HOMA-IR assayed (Li et al., 2014)
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Histological assessment
The pancreas of the mice were removed immediately 
and fixed in 10% formalin solution. Then, tissues 
were dehydrated in graded alcohol concentrations and 
embedded in paraffin. Sections of 4–6 µm were prepared 
and stained with hematoxylin & eosin (H&E). Six H&E 
stained slides per animal were examined for assessment 
of histological changes such as number and diameter of 
islets, which were determined by using Motic images plus 
2.0 image analysis software. Finally, a blind method was 
used for slide reading (Khorsandi, Nejad-Dehbashi, 2013).
Statistical analysis
Data are expressed as means ± S.E.M. Statistical 
comparison between different groups was performed using 
one-way analysis of variance (ANOVA) followed by a 
post-hoc Tukey HSD test, with p<0.05 being regarded as 
significant.
RESULTS AND DISCUSSION 
Effects of STZ-NA, metformin and BA treatment 
on blood glucose and α-amylase levels in mice
As shown in Table I, injection of STZ-NA raised 
blood glucose (Table I) and α-amylase (Figure 1) 
compared to saline groups (p<0.001 and p<0.05, 
respectively). However, no significant change (p>0.05) 
occurred in body weight.
The mean of fasting plasma glucose (Table I, 
p<0.001) and α-amylase concentration (Figure 1, 
p<0.05) decreased in BA- and metformin-treated 
animals compared to the diabetic group. The metformin 
administration showed no significant change compared to 
the BA groups. Therefore, betulinic acid may act through 
a similar mechanism to that of metformin.
TABLE I - Effect of different doses of betulinic acid on fasting glucose, insulin level, insulin biomarkers and body weight in STZ-
NA diabetic mice
Factors  
Groups 
Fasting 
glucose 
(mg/dl)
Insulin 
(µIU/ml) HOMA-IR HOMA-β QUICKI DI
Body weight 
(g)
Control 90.8±2.4 15.4±1.9 3.5±0.4 204.4±23.0 0.320±0.005 4.67±0.5 34.7±1.2
Sham 86.7±3.6 15.5±2.3 3.4±0.9 247.2±36.6 0.322±0.007 5.2±0.7 34.6±1.5
Diabetes 152.8±10.8 
###
14.7±1.9 5.5±0.7 
###
62.8±9.2 
#
0.300±0.004 
#
2.5±0.2 
#
35.7±1.2
Diabetes+10mg 81.8±2.9 
***
15.0±1.4 3.0±0.3 
***
315.9±45.8 
**
0.325±0.004 
**
5.5±0.5 
*
36.2±1.4
Diabetes+20mg 79.8±3.43 
***
14.1±1.5 2.8±0.4 
***
356.7±68.2 
***
0.330±0.006 
***
6.9±1.4 
***
34.5±1.7
Diabetes+40mg 79.2±2.8 
***
12.7±0.6 2.5±0.1 
***$
343.9±72.1 
***
0.333±0.002 
***
6.6±0.7 
**
35.2±1.7
Metformin 76.8±3.7 
***
13.5±1.8 2.6±0.4 
***
441.3±85.2 
***
0.334±0.006 
***
7.6±1.2 
***
32.3±1.2 
Data expressed as mean ± SEM. *p<0.05, **p<0.01 and, ***p<0.001 as compared with diabetic group; #p<0.05 and, ###p<0.001 as 
compared with control and sham groups, $ p<0.05 as compared with metformin group, n=10 (ANOVA and Tukey’s test). QUICKI= 
quantitative insulin sensitivity check index, DI = insulin disposition index.
FIGURE 1 - Effect of different doses of betulinic acid on 
α-amylase in STZ-NA diabetic mice. Data expressed as mean 
± SEM. *p<0.05, **p<0.01 and, ***p<0.001 as compared with 
diabetic group; #p<0.05 as compared with control and sham 
groups, n=10 (ANOVA and Tukey’s test).
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The type 2 diabetogenic effect of STZ-NA was 
previously reported (Lee et al., 2010). STZ-induced 
hyperglycemia can destroy pancreatic beta cells by 
induction of oxidative stress (Singh et al., 2007). 
Therefore, NA as an antioxidant can invert this effect and 
protect beta cells against the oxidant effect of STZ (Alenzi 
et al., 2009). In this study, it was shown that BA can reduce 
STZ-NA induced complications. Consistent with the 
present study, Lee et al. (2010) showed that ursolic acid (a 
triterpenoid of the ursane group) improved blood glucose 
levels in STZ-NA induced diabetic mice. They suggested 
that this effect may be due to inhibition of hepatic 
glucose production. Also, Chia et al. (2012) showed that 
treatment by glycyrrhetinic acid, the aglycone derivative 
of glycyrrhizinic acid, led to blood glucose levels being 
decreased in STZ-diabetic rats. Consistent with the present 
study, earlier studies have reported the effects of betulinic 
acid on high fat diet-induced diabetic mice (Kim et al., 
2014) and by oleanolic acid in STZ-diabetic mice (Gao et 
al., 2007). In agreement with the present study, isolated 
betulinic acid from S. cumini decreased plasma levels 
of α-amylase (Karthic et al., 2008). Because enzymes 
catalyze the most important biochemical pathways, 
enzyme inhibitors could be a potential target in many areas 
of disease control and treatment. In this aspect, amylase 
inhibitors are of particular importance (Kim, Nho, 2004).
Metformin is a biguanide antidiabetic medication 
that lowers blood glucose through inhibition of 
gluconeogenesis and increases utilization of glucose 
in liver, muscle and intestine (Hundal et al., 2000) and 
shows efficacy in reducing type 2 diabetes in mice (Lee 
et al., 2010). Therefore, we used metformin to compare 
its effects with BA treated groups, as a positive control. 
In this study, administration of metformin for 2 weeks 
in STZ-NA induced diabetic mice decreased blood 
glucose and α-amylase. The favorable effects exerted by 
BA on the level of blood glucose and α-amylase were 
similar to metformin treatment. The combination therapy 
with metformin and oleanolic acid was shown to have 
synergistic effects by improving glucose homeostasis in 
type 2 diabetes (Wang et al., 2015).
Effects of STZ-NA, metformin and BA treatment 
on insulin and insulin sensitivity biomarkers in 
mice
Plasma insulin levels had no significant difference 
between BA groups compared to the diabetic control 
group. In addition, there was no significant difference 
between metformin groups compared to BA groups 
(p>0.05, Table I).
Insulin resistance was assessed by using the 
HOMA-IR and QUICKI indexes. Insulin sensitivity was 
reduced, as revealed by increased HOMA-IR (p < 0.001) 
concomitantly with reduction of HOMA- β and QUICKI 
values (p < 0.05), observed in the diabetic control group. 
After 2 weeks of treatment, BA, diabetic + BA 10, 20 
and 40 mg/kg groups possessed significantly increased 
HOMA-β, QUICKI and DI values compared to the 
diabetic control group (p < 0.01, p < 0.001 and p < 0.001, 
respectively). With the metformin group, this biomarker 
did not significantly alter compared to BA groups 
(Table I). HOMA-IR, HOMA-β, QUICKI and DI were 
calculated to investigate the health of insulin-producing 
cells and function of insulin. HOMA-IR was used to 
quantify insulin resistance and HOMA-β was used to 
quantify β-cell function. HOMA-β and QUICKI correlate 
with HOMA-IR (Dube et al., 2013). The results show that 
treatment with BA in STZ-NA diabetic mice decreased 
HOMA-IR compared with the control group. Also, Chia 
et al. (2012) showed that treatment with glycyrrhizinic 
acid (a triterpenoid of the ursane group) decreased 
HOMA-IR due to a decrease in the gluconeogenesis rate-
limiting enzymes. Consistent with our study, treatment 
with betulin improved insulin sensitivity (Tang et al., 
2011). However, in the administration of BA as an 
anti-diabetic agent, side effects such as those on the 
reproductive system should be considered (Ahangarpour 
et al., 2016c).
Administration of metformin for 2 weeks in STZ-
NA induced diabetic mice decreased insulin resistance 
and increased other insulin biomarkers. The favorable 
effects exerted by BA on the insulin biomarkers are 
similar to those associated with metformin treatment. 
The combination therapy with metformin and oleanolic 
acid was shown to have synergistic effects by improving 
insulin production in type 2 diabetes (Wang et al., 2015).
Effects of STZ-NA, metformin and BA on 
pancreas histology 
The exocrine part of the pancreas in all control 
and treatment groups showed a normal appearance, and 
all pancreas sections revealed a normal appearance in 
control and sham groups. The islet numbers were reduced 
dramatically in the diabetic group (p < 0.001); BA at 
different doses could significantly reverse the number of 
islets in a dose-dependent manner. The diameter of islets 
was reduced significantly in diabetic animals (p < 0.001), 
but increased in BA treatment groups in comparison to 
positive control groups. This effect of BA (from 10 to 
40mg) was also dose dependent, with 40 mg/kg BA being 
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found to be more effective on the increase of islet diameter 
(Table II and Figure 2). 
In type 2 diabetes, beta-cell function and mass is 
lost progressively. The histological assessment of diabetic 
treated groups indicates an increase in the diameters and 
number of pancreatic islets and β-cell function in the group 
which received BA treatments, which may be illustrative 
of pancreatic islet regeneration. In addition, betulinic 
acid showed stronger effects on the pancreatic histology 
compared to the metformin group. This result may relate 
to the antioxidant effect of BA. In agreement with this 
study, glycyrhizinic acid can increase the diameter and 
count of pancreatic islets (Sen, Roy, Chakraborti, 2011). 
Also, an increase in β-cell function has been reported for 
other triterpenes (Jang et al., 2009). 
CONCLUSION
This study demonstrated that BA can effectively 
decrease blood glucose, α-amylase levels and increase 
numbers and diameters of islets in animal type 2 diabetes. 
Although insulin levels did not change, insulin resistance 
decreased in BA-treated mice. In the other words, 
betulinic acid has hypoglycemic properties, which could 
be explained by improved insulin resistance and/or 
pancreatic islet regenerative effects of betulinic acid in 
STZ-NA diabetic mice. The dose-dependent effect of BA 
is observed only in the pancreas histology, with a more 
pronounced effect exerted by the highest concentration 
of BA tested. A higher concentration is likely required 
to produce better histological changes. Further clinical 
FIGURE 2 - Effect of different doses of betulinic acid on islets and pancreas histological analysis in STZ-NA diabetic mice. A: 
Control, B: Diabetic, C: Diabetic+BA10mg, D: Diabetic+BA20mg, E: Diabetic+BA40mg, F: Metformin. (H&E stain × 400). 
Arrow: Islets of Langerhans.
TABLE II - Effect of different doses of betulinic acid on pancreatic islets diameter and number in STZ-NA diabetic mice
Factors  
Groups 
Control Sham Diabetes Diabetes +
10mg
Diabetes +
20mg
Diabetes + 
40mg
Metformin
Diameter (µm) 118.3±9.4 106.6±5.9 76.9±6.7 
##
94.6±6.2 98.3±5.8 127.0±4.9 
***$$$
106.7±8.6 
*
Number 5.0±0.0 4.3±0.3 2.0±0.0 
###
6.0±0.0 
***
6.3±0.3 
***
7.3±0.3 
***$$S
4.3±0.9 
***
Data are expressed as mean ± SEM. *p<0.05, and ***p<0.001 as compared with diabetic group; ##p<0.01 and, ###p<0.001 as compared 
with control and sham groups, $$$ p<0.001 as compared with metformin group, n=10 (ANOVA and Tukey’s test).
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studies are required to support this proposal and also to 
establish the beneficial effects of betulinic acid on blood 
glucose levels and insulin resistance.
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